CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system.
52W Range
42ndpctl
Volume
0.00×avg
Market Cap
8.07MUSD
P/E Ratio
-0.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
CNS Pharmaceuticals, Inc.
CNSPNASDAQ Capital Market·USD·Closed
CNS Pharmaceuticals, Inc.
CNSPNASDAQ·USD·Closed
$5.52
+0.10%
$5.52
+$0.01 (0.10%)
52W Range
42ndpctl
Volume
0.00×avg
Mkt Cap
8.07MUSD
P/E
-0.2TTM
Div Yield
–ann
CNSP: CNS Pharmaceuticals, Inc. Stock Analysis | finqOS
